North Rolling Hills Estates, CA, United States of America

Chad K Oh


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chad K Oh: Innovator in Respiratory Health

Introduction

Chad K Oh is a notable inventor based in North Rolling Hills Estates, California, who has made significant contributions to the field of respiratory health. With a particular focus on innovative treatment methods, he has developed a patented approach that offers new hope for individuals suffering from asthma and chronic obstructive pulmonary disease (COPD).

Latest Patents

Chad K Oh holds a patent for the "Use of antagonists of plasminogen activator inhibitor-1 (PAI-1) for the treatment of asthma and chronic obstructive pulmonary disease." This groundbreaking invention outlines methods for treating these conditions through the administration of antagonists to PAI-1. The suitable antagonists identified in the patent include antibodies, peptides, proteins, nucleic acids, small organic molecules, and polymers. This innovation has the potential to enhance therapeutic options for patients and improve their quality of life.

Career Highlights

Chad K Oh’s career is marked by his dedication to research and innovation in respiratory health. He has successfully translated scientific insights into practical applications, culminating in a valuable patent that addresses significant medical challenges. His work at Tanox, Inc. exemplifies his commitment to advancing medical treatments and underscores his role as a key contributor in his field.

Collaborations

Throughout his career, Chad has collaborated with talented individuals such as Seong Hee Cho and Sossiena Demissie-Sanders. These partnerships highlight the importance of teamwork in innovation, as diverse expertise often leads to more robust solutions in research and development.

Conclusion

Chad K Oh stands out as an inventor dedicated to advancing respiratory health through innovative therapeutic methods. His patent for the use of PAI-1 antagonists exemplifies his ingenuity and commitment to improving patient outcomes. With ongoing collaboration and research, his contributions could pave the way for enhanced treatments in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…